Why we lose muscle with age, and what actually slows it
Muscle loss with age, sarcopenia, is part inevitable, mostly modifiable. What the population data, including our own umbrella review, says really works, and what doesn't.
Somewhere in your forties, if nothing intervenes, your muscle begins a slow retreat. It is quiet at first, a little less power on the stairs, a jar that needs a second try. By eighty, an untrained person may have lost a third or more of the muscle they had at thirty. The medical name for this is sarcopenia, and it is one of the most consequential, least discussed processes in human ageing. Weak muscle is not just weakness. It is falls, fractures, lost independence, and, measurably, earlier death.
This is the second essay in a thread that runs through much of my work: how ageing, activity, nutrition and chronic inflammation intersect across tissues. These processes overlap, but they are not interchangeable explanations.
What is actually being lost
Muscle is not a fixed possession; it is a balance. Every day your body both builds muscle protein and breaks it down, and a healthy young system keeps the two roughly even. With age, the balance tips. Three things conspire.
First, the building signal weakens. Older muscle responds less to the usual triggers, protein in a meal, the strain of a load. Scientists call this anabolic resistance: the same stimulus produces less growth than it once did.
Second, the breakdown signal strengthens, and here is the inflammation link. Ageing fat tissue and a generally more inflamed internal environment, “inflammaging”, release signalling molecules that quietly favour muscle breakdown. In our own meta-analyses on sarcopenia, the pattern that keeps appearing is that markers of inflammation and dysfunctional fat travel together with lost muscle and grip strength. The body, in effect, starts spending muscle to feed a low-grade fire.
Third, the wiring frays. The nerves that command muscle fibres are themselves lost with age, and orphaned fibres waste.
None of this is a moral failing or simple disuse. It is biology. But, and this is the whole point, the rate at which it happens is extraordinarily modifiable.
What actually works
In an umbrella review of meta-analyses on physical activity, sedentary behaviour and mortality, my colleagues and I found that greater physical activity was consistently associated with better health outcomes. The evidence is important, but population associations do not determine the best programme for one person.
Two kinds matter most.
Progressive resistance training is a central evidence-based strategy for maintaining or improving strength in later life. Programmes need to match a person’s starting ability, health, balance, technique and access to appropriate supervision.
Adequate nutrition, including protein. Needs differ with body size, diet, kidney function, illness and activity. Distribution across meals may be useful, but a safe target should be individualised when health conditions are present.
Around these two, the supporting cast: staying generally active rather than sedentary, treating the small illnesses that cause weeks of bed rest (each of which costs muscle that is hard to win back), and protecting sleep.
What doesn’t
It is worth being just as clear about what the evidence does not support. There is no pill that rebuilds aged muscle the way training does. The supplement aisle sells a great deal of hope here, and most of it is, charitably, modest. Where a supplement displaces the thing that actually works, the boring, effortful lifting, it does harm by omission.
Research into senescent cells, inflammatory pathways and anabolic signalling is active, but laboratory promise is not routine treatment. Current care still relies heavily on appropriately prescribed activity, nutrition and management of contributing illness.
What this means for you
Maintaining strength and activity across adulthood is associated with better function later in life. Improvement can remain possible at older ages, although response and safety vary between people.
That is the quietly hopeful part of this work. The fundamentals are not effortless or universally free, and access matters, but appropriately supported movement remains a practical part of healthy ageing.
This essay draws on our umbrella review of physical activity and mortality in the Journal of Cachexia, Sarcopenia and Muscle and our work on adipose dysfunction and inflammatory markers in sarcopenia in Age and Ageing*. It is education, not personal medical advice, before starting resistance training, especially with existing conditions, talk to a clinician who knows you.*